High radiation dose in chemoradiotherapy followed by immunotherapy with durvalumab in patients with stage III non-small cell lung cancer does not increase risk for pneumonitis.

Strahlenther Onkol · 2025 · PMC12119742 · PMID 39945842

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

a favorable trendp = 0.057so close (0.05 < p ≤ 0.1)

There was no significant difference in incidence of death between the groups, but there was a favorable trend towards the 70 Gy arm compared to the < 70 Gy group ( p = 0.057).

also in 466 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.